Recent News

• 05.21.2026 - CORRESP - Correspondence
• 05.21.2026 - UPLOAD - SEC-generated letter
• 05.20.2026 - DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 05.20.2026 - DEF 14A - Definitive proxy statements
• 05.19.2026 - Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21
• 05.19.2026 - 8-K - Current report
• 05.18.2026 - ORAGENICS PROVIDES INVESTOR UPDATE
• 05.08.2026 - PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition
• 05.08.2026 - 10-Q - Quarterly report [Sections 13 or 15(d)]
• 05.07.2026 - Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation

Recent Filings

• 05.20.2026 - DEF 14A Other definitive proxy statements
• 05.20.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 05.19.2026 - 8-K Current report
• 05.19.2026 - EX-99.1 EX-99.1
• 05.08.2026 - PRE 14A Other preliminary proxy statements
• 05.08.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.07.2026 - EX-99.1 EX-99.1
• 05.07.2026 - 8-K Current report